https://www.selleckchem.com/pr....oducts/kg-501-2-naph
Survival analysis found significant differences for SCE and CSS depending on these three parameters. Metabolic parameters MTV and TLG, and tumor size were prognostic factors for neoadjuvant treatment response, PFS, and CSS in patients diagnosed with SCC. Neither SUVmax nor SUVmed were predictive for any of the evaluation criteria. Results could help to personalize patient treatment. Metabolic parameters MTV and TLG, and tumor size were prognostic factors for neoadjuvant treatment response, PFS, and CSS in patien
Like
Comment
Share
